The latest on MDS, its prognosis and its treatment

To support the unmet need of the MDS community globally, the MDS Alliance has translated three webinars into the following languages: Spanish, Italian, French, Chinese (Mandarin), Hindi, Turkish, Greek, Serbian, Polish and German. Watch the webinars below!

To select the language of the subtitles:

  1. Click on the video
  2. Click on the Settings icon (a little cog at the bottom right corner – just before the word YouTube)
  3. Select the Subtitles option
  4. Select the language of your choice

The MDS Foundation has kindly gifted the MDS Alliance these webinars for patients with MDS and caregivers.

  1. What is MDS? How do we determine prognosis?

Speaker: Jamile Shammo, MD; Rush University Medical Center, US

This webinar provides an overview of MDS and how prognosis is determined, focusing on the MDS subtypes and disease process of MDS. Understanding the diagnosis of MDS, and the details about the various approaches to treatment, and answers to common questions are discussed.


  1. Treatment of high-risk MDS and the indication for stem cell transplant

Speaker: Prapti Patel, MD; UT Southwestern Medical Center, US

This webinar provides an overview of high-risk MDS, secondary AML, and indication for stem cell transplant, focusing on strategies for patient management. Risk assessment, treatment options, as well as resources for patients and caregivers are discussed.

  1. Low-risk MDS: Can we prevent progression?

Speaker: Casey L. O’Connell, MD; Keck School of Medicine of USC, US

This webinar provides an overview, summarizing changes in the treatment landscape for patients with low-risk MDS. The concerns of patients with low-risk MDS and their caregivers are addressed.


We would like to thank Bristol Myers Squibb for providing the funding for the translation of subtitles for this project.  

Translate »